Clarity COVID-19 Rapid Antigen Test is a quick and easy test providing rapid results in as fast as 5 minutes. The test is FDA Emergency Use Authorized, CLIA Waived and POCT approved. It has a relative sensitivity of 87.5% and a relative specificity of >98.9%.The Clarity COVID-19 Rapid Antigen Test is a type of antigen test designed to detect proteins from the virus that causes COVID-19 in nasopharyngeal swabs. The presence of viral proteins indicate you may have been infected with the virus and are likely to be contagious. If you have a positive test result, it is highly likely that you have contracted COVID-19 because of the presence of proteins from the virus were discovered in your sample. Due to FDA Guidelines and Supply Chain Demands All Orders for this Product are NON-Cancellable and NON-Returnable. By purchasing the Clarity Antigen Test from Wilburn Medical you agree to the following guidelines: This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC) by qualified healthcare professionals, i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
UOM: Case (25 tests/box, 49 boxes/cs)
Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.
Product Features:
- Economically Priced
- FDA EUA Approved
- Relative Sensitivity 887.5%
- Relative Specificity >98.9%
- Test Naso-Pharyngeal Swab
- Naso-Pharyngeal Swab stored in dry tube (at 2-8 degrees C can be tested within 24 hours)
- Fast & Easy (positive results as fast as 5 minutes)
- 25 Individually Pouched Test Cassettes
- 25 Sterile Nasopharyngeal Swabs
- 25 Buffer Tubes
- 1 Negative Control Swab
- 1 Positive Control Swab
- 1 Work Station
- 1 Package Insert
- FDA EUA
- Package Insert
- Fact Sheet for Healthcare Providers
- Fact Sheet for Recipients
- MDS SDS CLA-COV19AF-VIS
- Test Performance against Variants
Specifications
| Test type | Naso-Pharyngeal Swab |
| Specimen type | Anterior nasal (AN) |
| Turnaround time | 5 minutes |
| CLIA complexity | CLIA Waived and POCT approved. |
| FDA status | Emergency Use Authorization (EUA) granted |
| Packaging |
(25 tests/box, 49 boxes/cs) |
Resources
Clarity COVID-19 Rapid Antigen Test is a quick and easy test providing rapid results in as fast as 5 minutes. The test is FDA Emergency Use Authorized, CLIA Waived and POCT approved. It has a relative sensitivity of 87.5% and a relative specificity of >98.9%.The Clarity COVID-19 Rapid Antigen Test is a type of antigen test designed to detect proteins from the virus that causes COVID-19 in nasopharyngeal swabs. The presence of viral proteins indicate you may have been infected with the virus and are likely to be contagious. If you have a positive test result, it is highly likely that you have contracted COVID-19 because of the presence of proteins from the virus were discovered in your sample. Due to FDA Guidelines and Supply Chain Demands All Orders for this Product are NON-Cancellable and NON-Returnable. By purchasing the Clarity Antigen Test from Wilburn Medical you agree to the following guidelines: This test has not been FDA cleared or approved; the test has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform moderate, high or waived complexity tests. This test is authorized for use at the Point of Care (POC) by qualified healthcare professionals, i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
UOM: Case (25 tests/box, 49 boxes/cs)
Bulk Orders - For bulk orders, please fill out the "Request Unbeatable Bulk Quote" form to the right or contact us at info@mersidistribution.com or (800) 654-0186.
Product Features:
- Economically Priced
- FDA EUA Approved
- Relative Sensitivity 887.5%
- Relative Specificity >98.9%
- Test Naso-Pharyngeal Swab
- Naso-Pharyngeal Swab stored in dry tube (at 2-8 degrees C can be tested within 24 hours)
- Fast & Easy (positive results as fast as 5 minutes)
- 25 Individually Pouched Test Cassettes
- 25 Sterile Nasopharyngeal Swabs
- 25 Buffer Tubes
- 1 Negative Control Swab
- 1 Positive Control Swab
- 1 Work Station
- 1 Package Insert
- FDA EUA
- Package Insert
- Fact Sheet for Healthcare Providers
- Fact Sheet for Recipients
- MDS SDS CLA-COV19AF-VIS
- Test Performance against Variants
Specifications
| Test type | Naso-Pharyngeal Swab |
| Specimen type | Anterior nasal (AN) |
| Turnaround time | 5 minutes |
| CLIA complexity | CLIA Waived and POCT approved. |
| FDA status | Emergency Use Authorization (EUA) granted |
| Packaging |
(25 tests/box, 49 boxes/cs) |
Resources
1225/CS Clarity COVID-19 Rapid Antigen Test Cassettes Price List
| Store | Price | ||
|---|---|---|---|